Journal of the American Geriatrics Society,
Год журнала:
2023,
Номер
72(1), С. 126 - 138
Опубликована: Дек. 20, 2023
Abstract
Background
Potentially
inappropriate
medications
(PIMs)
in
older
adults
are
which
risks
often
outweigh
benefits
and
suggested
to
be
avoided.
Worldwide,
many
distinct
guidelines
tools
classify
PIMs
adults.
Collating
these
tools,
mapping
them
a
medication
classification
system,
creating
crosswalk
will
enhance
the
utility
of
PIM
guidance
for
research
clinical
practice.
Methods
We
used
Anatomical
Therapeutic
Chemical
(ATC)
Classification
System,
hierarchical
map
from
eight
(2019
Beers
Criteria,
Screening
Tool
Older
Person's
Appropriate
Prescriptions
[STOPP],
STOPP‐Japan,
German
PRISCUS,
European
Union‐7
Inappropriate
Medication
[PIM]
list,
Centers
Medicare
&
Medicaid
Services
[CMS]
High‐Risk
Medication,
Anticholinergic
Burden
Scale,
Drug
Index).
Each
was
mapped
ATC
Level
5
(drug)
4
(drug
class).
then
(1)
compare
drug
classes
across
determine
number
that
were
index
(drug‐induced
adverse
event)
or
marker
(treatment
drug‐induced
prescribing
cascades,
(2)
estimate
prevalence
use
continuously
enrolled
with
fee‐for‐service
2018
as
cases.
Data
visualization
descriptive
statistics
assess
both
Results
Out
480
unique
identified,
only
three
medications—amitriptyline,
clomipramine,
imipramine
two
classes—N06AA
(tricyclic
antidepressants)
N06AB
(selective
serotonin
reuptake
inhibitors),
noted
all
tools.
Using
crosswalk,
50%
drugs
47%
known
cascades
PIMs.
Additionally,
88%
beneficiaries
dispensed
≥1
Conclusion
created
system
Our
findings
could
expand
ease
identification
harmonization
practice
purposes.
Therapeutics and Clinical Risk Management,
Год журнала:
2021,
Номер
Volume 17, С. 927 - 949
Опубликована: Сен. 1, 2021
Abstract:
The
rising
of
global
geriatric
population
has
contributed
to
increased
prevalence
dementia.
Dementia
is
a
neurodegenerative
disease,
which
characterized
by
progressive
deterioration
cognitive
functions,
such
as
judgment,
language,
memory,
attention
and
visuospatial
ability.
not
only
profoundly
devastating
physical
psychological
health
outcomes,
but
it
also
poses
considerable
healthcare
expenditure
burdens.
Acetylcholinesterase
inhibitors
(AChEIs),
or
so-called
anti-dementia
medications,
have
been
developed
delay
the
progression
neurocognitive
disorders
decrease
needs.
AChEIs
widely
prescribed
in
clinical
practice
for
treatment
Alzheimer's
account
70%
use
results
adverse
drug
reactions
(ADRs)
cardiovascular
gastrointestinal
effects,
resulting
from
overstimulation
peripheral
cholinergic
activity
muscarinic
receptor
activation.
Changes
pharmacokinetics
(PK),
pharmacodynamics
(PD)
pharmacogenetics
(PGx),
occurrence
interactions
are
said
be
major
risk
factors
ADRs
this
population.
To
date,
comprehensive
reviews
so
far
scarcely
studied.
Therefore,
we
aimed
recapitulate
update
diverse
aspects
AChEIs,
including
mechanisms
action,
characteristics
ADRs,
preventive
strategies
their
ADRs.
collation
knowledge
essential
facilitate
efforts
reduce
AChEIs.
Keywords:
older
adults,
dementia,
acetylcholinesterase
inhibitors,
reactions,
drug–drug
Drugs & Aging,
Год журнала:
2023,
Номер
40(12), С. 1085 - 1100
Опубликована: Окт. 20, 2023
To
reduce
prescribing
cascades
occurring
in
clinical
practice,
healthcare
providers
require
information
on
the
they
can
recognize
and
prevent.
This
systematic
review
aims
to
provide
an
overview
of
cascades,
including
dose-dependency
recommendations
that
use
prevent
or
reverse
them.
The
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-Analyses
(PRISMA)
was
followed.
Relevant
literature
identified
through
searches
OVID
MEDLINE,
Embase,
CINAHL,
Cochrane.
Additionally,
Web
Science
Scopus
were
consulted
analyze
reference
lists
citations.
Publications
English
included
if
analyzed
occurrence
cascades.
Prescribing
at
least
one
study
demonstrated
a
significant
association
excluded
when
adverse
drug
reaction
could
not
be
confirmed
Summary
Product
Characteristics.
Two
reviewers
independently
extracted
grouped
similar
Descriptive
summaries
provided
regarding
analyses
these
A
total
95
publications
included,
resulting
115
with
reactions
which
found.
For
52
dose
dependency
Dose
12
example,
antipsychotics
may
cause
extrapyramidal
syndrome
followed
by
anti-parkinson
drugs.
Recommendations
focused
dosage
lowering,
discontinuing
medication,
medication
switching.
Explicit
alternative
options
given
three
One
example
switching
ondansetron
granisetron
is
experienced
using
metoclopramide.
In
total,
them
generated
provided.
Nonetheless,
managing
scarce.
Translational Psychiatry,
Год журнала:
2024,
Номер
14(1)
Опубликована: Июнь 1, 2024
Abstract
The
explosion
and
abundance
of
digital
data
could
facilitate
large-scale
research
for
psychiatry
mental
health.
Research
using
so-called
“real
world
data”—such
as
electronic
medical/health
records—can
be
resource-efficient,
rapid
hypothesis
generation
testing,
complement
existing
evidence
(e.g.
from
trials
evidence-synthesis)
may
enable
a
route
to
translate
into
clinically
effective,
outcomes-driven
care
patient
populations
that
under-represented.
However,
the
interpretation
processing
real-world
sources
is
complex
because
important
‘signal’
often
contained
in
both
structured
unstructured
(narrative
or
“free-text”)
data.
Techniques
extracting
meaningful
information
(signal)
text
exist
have
advanced
re-use
routinely
collected
clinical
data,
but
these
techniques
require
cautious
evaluation.
In
this
paper,
we
survey
opportunities,
risks
progress
made
use
medical
record
(real-world)
psychiatric
research.
PLoS ONE,
Год журнала:
2022,
Номер
17(8), С. e0272418 - e0272418
Опубликована: Авг. 31, 2022
Background
Prescribing
cascades,
where
a
medication
is
used
to
treat
the
side
effect
of
another
medication,
contribute
polypharmacy
and
related
morbidity.
Little
known
about
clinicians’
patients’
experiences
with
prescribing
cascades.
In
this
study,
we
explored
why
how
cascades
occur
across
variety
care
settings
they
are
managed.
Methods
findings
This
descriptive
qualitative
study
employed
semi-structured
interviews
older
adults
who
may
have
experienced
cascade(s),
their
caregivers,
healthcare
providers.
Interviewees
were
recruited
through
physician
referral
from
Geriatric
Day
Hospital,
two
long-term
homes
in
Ottawa,
Ontario,
self-referral
Canada.
An
inductive
approach
was
code
data
determine
themes.
Thirty-one
conducted
for
ten
unique
patient
cases.
Some
interviewees
involved
more
than
one
case,
resulting
22
interviewees.
Three
themes
identified.
First,
recognition
linked
awareness
effects.
Second,
investigation
management
simultaneous
iterative
(rather
linear
sequential).
Third,
prevention
requires
intentional
strategies
help
people
anticipate
recognize
Difficulty
recruitment
both
central
limitation.
exemplifies
challenges
associated
studying
poorly
recognized
underexplored
phenomenon.
Conclusions
order
better
recognize,
investigate
manage
clinicians
patients
need
know
effects;
ask
‘can
be
caused
by
drug?’
when
signs
symptoms
arise
or
worsen;
access
information
benefit-risk
discussions
make
decisions
deprescribing.
Approaches
raising
public
should
trialed
raise
profile
issue
facilitate
continued
exploration
Pharmacology Research & Perspectives,
Год журнала:
2022,
Номер
10(5)
Опубликована: Сен. 19, 2022
Abstract
The
misattribution
of
an
adverse
drug
reaction
(ADR)
as
a
symptom
or
illness
can
lead
to
the
prescribing
additional
medication,
referred
cascade.
aim
this
systematic
review
is
identify
published
cascades
in
community‐dwelling
adults.
A
was
reported
line
with
PRISMA
guidelines
and
pre‐registered
PROSPERO.
Electronic
databases
(Medline
[Ovid],
EMBASE,
PsycINFO,
CINAHL,
Cochrane
Library)
grey
literature
sources
were
searched.
Inclusion
criteria:
adults;
risk‐prescription
medication;
outcomes‐initiation
new
medicine
“treat”
reduce
ADR
risk;
study
type‐cohort,
cross‐sectional,
case‐control,
case‐series
studies.
Title/abstract
screening,
full‐text
data
extraction,
methodological
quality
assessment
conducted
independently
duplicate.
narrative
synthesis
conducted.
total
101
studies
(reported
103
publications)
included.
Study
sample
sizes
ranged
from
126
11
593
989
participants
15
examined
older
adults
specifically
(≥60
years).
Seventy‐eight
potential
cascade
including
calcium
channel
blockers
loop
diuretic
(
n
=
5),
amiodarone
levothyroxine
inhaled
corticosteroid
topical
antifungal
4),
antipsychotic
anti‐Parkinson
acetylcholinesterase
inhibitor
urinary
incontinence
drugs
4).
Identified
occurred
within
three
months
one
year
following
initial
medication.
Methodological
varied
across
included
Prescribing
occur
for
broad
range
medications.
ADRs
should
be
differential
diagnosis
patients
presenting
symptoms,
particularly
those
who
started
medication
preceding
12
months.
Healthcare,
Год журнала:
2023,
Номер
11(12), С. 1665 - 1665
Опубликована: Июнь 6, 2023
A
prospective
cross-sectional
study
was
conducted
to
analyse
the
drugs
prescribed
elderly
population
with
noncommunicable
diseases
and
determine
polypharmacy
at
a
primary
care
clinic
in
Negeri
Sembilan,
Malaysia.
The
for
6
months
of
Gemas.
Geriatric
patients
above
age
65
diagnosed
were
included
upon
providing
written
informed
consent.
majority
geriatric
between
69
years
(mean:
69.72
±
2.85)
4
or
more
medications
5.18
0.64,
p
=
0.007).
More
than
95%
(n
295)
geriatrics
found
have
multimorbidity,
which
around
45%
139)
had
type-2
diabetes
together
hypertension
dyslipidaemia.
Combination
therapy
97%
302)
elderly,
whereas
cardiovascular
endocrine
most
commonly
prescribed.
Ten
prescriptions
drug-related
problems,
prescribing
cascade
(80%),
lack
medicine
optimisation
(10%),
inappropriate
prescription
(10%).
In
this
study,
multimorbidity;
seen
among
patients.
Polypharmacy
is
biggest
threat
population,
as
it
increases
chances
falls
fall-related
injuries.
Medicine
deprescribing
will
reduce
problems
morbidity
mortality
associated
over-consumption
medications.
Hence,
recommends
health
fraternity
look
medication
future
complications
polypharmacy.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy,
Год журнала:
2023,
Номер
44(1), С. 87 - 96
Опубликована: Сен. 25, 2023
The
strength
of
evidence
for
specific
ambulatory
care
prescribing
cascades,
in
which
a
marker
drug
is
used
to
treat
an
adverse
event
caused
by
index
drug,
has
not
been
well
characterized.
To
perform
structured,
systematic,
and
transparent
review
the
supporting
cascades.
Ninety-four
potential
cascades
identified
through
previously
published
systematic
review.
Systematic
search
literature
further
characterize
(1)
Grading
based
on
observational
studies
investigating
associations
between
drugs,
including:
Level
I-strong
[i.e.
multiple
high-quality
studies];
II-moderate
single
study];
III-fair
[no
but
one
or
more
moderate-quality
IV-poor
[other].
(2)
Listing
associated
with
product's
United
States
Food
Drug
Administration
(FDA)
label.
(3)
Synthesis
mechanisms
linking
drugs
events.
Of
99
94
were
supported
confirmatory
therefore
included
this
related
30
types
reactions
affecting
10
different
anatomic/physiologic
systems
investigated
total
88
studies,
including
prescription
sequential
symmetry
analysis
(n
=
51),
cohort
30),
case-control
7)
studies.
Overall,
from
was
strong
18
(19.1%)
moderate
61
(64.9%),
fair
13
(13.8%),
poor
2
(2.1%).
Although
that
link
events
variable,
FDA
labels
information
about
most
86)
all
we
clinical
are
label,
evidentiary
basis
varies,
many
requiring
relevance.
Frontiers in Pharmacology,
Год журнала:
2023,
Номер
14
Опубликована: Июль 3, 2023
Background:
The
concept
of
prescribing
cascades
has
been
proposed
for
more
than
20
years,
but
the
research
progress
and
cognitive
level
varied
in
different
countries.
aim
this
study
was
to
systematically
evaluate
current
status
relevant
original
on
cascades,
provide
references
further
continuous
improvement
clinical
practice.
Methods:
We
searched
three
English
databases
four
Chinese
from
inception
until
January
2022.
Relevant
studies
about
meeting
eligibility
criteria
were
extracted
independently
by
two
reviewers,
a
descriptive
analysis
conducted
compare
methods
outcomes
included
studies.
Results:
A
total
32
involving
7,075,200
patients
11
countries
included,
including
13
cross-sectional
studies,
case
reports,
7
cohort
1
case-control
study.
target
population
mainly
elderly
people
(24
studies).
purpose
could
be
divided
into
categories:
prevention
(4
studies),
identification
(17
resolution
(11
studies)
cascades.
49
cascade
routes
identified
attributed
cardiovascular
system,
most
primary
diseases
which
dementia,
initial
medications
calcium
channel
blockers,
six
drugs
involved
routes.
Conclusion:
Prescribing
have
attracted
attention
internationally
focused
their
nervous
diseases,
still
not
yet
formed
integral
other
special
populations
drug
use,
such
as
children
pregnant
women.
It
is
necessary
conduct
in-depth
with
broader
range,
establish
series
effective
measures
decrease
incidence
high-risk
group
use.
Drug Safety,
Год журнала:
2024,
Номер
47(8), С. 771 - 781
Опубликована: Май 13, 2024
Adverse
drug
reactions
(ADRs)
are
common
among
people
with
dementia;
however,
little
is
known
about
the
magnitude
and
predictors
associated
ADR-related
hospitalisation
these
individuals.
This
study
aimed
to
determine
magnitude,
types,
drugs
implicated
of
ADRs
dementia.
retrospective
case-control
analysed
medical
records
individuals
aged
≥
65
years
dementia
admitted
major
public
hospitals
in
Tasmania,
Australia,
from
July
2010
2021.
were
identified
using
administrative
data
cross-checked
hospital
records,
consensus
reached
research
team.
Of
7928
at
least
once
within
period,
1876
(23.7%)
experienced
one
hospitalisation.
these,
300
case
patients
311
control
randomly
selected.
The
most
types
renal
(acute
kidney
injury;
AKI)
(36.0%),
followed
by
neuropsychiatric
(17.6%),
cardiovascular
(16.0%)
haematological
(13.1%).
Diuretics,
renin-angiotensin
system
(RAS)
inhibitors
anti-thrombotics
constituted
main
classes.
was
with:
chronic
disease
(CKD)
(OR
8.00,
95%
CI
2.63–24.28,
p
<
0.001),
Australian-born
1.62,
1.08–2.43,
=
0.019),
hypertension
1.48,
1.01–2.17,
0.044)
number
medicines
1.06,
1.00–1.12,
0.022).
Potentially
inappropriate
medication
use
anticholinergic
burden
did
not
predict
These
could
help
identify
highest
risk
enable
targeted
interventions
be
designed.
Journal of the American Geriatrics Society,
Год журнала:
2022,
Номер
71(2), С. 505 - 515
Опубликована: Окт. 26, 2022
Abstract
Background
The
use
of
a
new
medication
(e.g.,
potassium
supplementation)
for
managing
drug‐induced
adverse
event
loop
diuretic‐induced
hypokalemia)
constitutes
prescribing
cascade.
However,
diuretics
are
often
stopped
while
may
be
unnecessarily
continued
(i.e.,
relic).
We
aimed
to
quantify
the
occurrence
relics
using
older
adults
previously
experiencing
diuretic‐potassium
cascade
as
an
example.
Methods
conducted
prescription
sequence
symmetry
analysis
population‐based
Medicare
Fee‐For‐Service
data
(2011–2018)
and
partitioned
150
days
following
initiation
by
day
assess
daily
treatment
scenarios
alone,
combination
potassium,
or
neither).
calculated
proportion
patients
developing
relic,
person‐days
under
probability
filling
after
diuretic
discontinuation.
also
identified
risk
factors
relic.
Results
284,369
initiators
who
were
8
times
more
likely
receive
supplementation
simultaneously
cascade),
rather
than
before,
(aSR
8.0,
95%
CI
7.9–8.2).
Among
66,451
subsequently
(≤30
days)
initiated
20,445
(30.8%)
remained
on
discontinuation,
9365
(14.1%)
filled
another
supplementation.
Following
initiation,
4.0%
relic
was
highest
90
(5.6%).
Older
age,
female
sex,
higher
dose,
greater
baseline
comorbidities
having
same
prescriber
pharmacy
involved
in
both
medications
less
experience
Conclusions
Our
findings
suggest
need
clinicians
aware
potential
avoid
unnecessary
drug
use.